4.7 Article Proceedings Paper

Neuroprotective properties of resveratrol and derivatives

Journal

RESVERATROL AND HEALTH
Volume 1215, Issue -, Pages 103-108

Publisher

WILEY-BLACKWELL
DOI: 10.1111/j.1749-6632.2010.05865.x

Keywords

stilbenoid; Alzheimer's disease; beta-amyloid peptide; inhibition of aggregation

Ask authors/readers for more resources

Stilbenoid compounds consist of a family of resveratrol derivatives. They have demonstrated promising activities in vitro and in vivo that indicate they may be useful in the prevention of a wide range of pathologies, such as cardiovascular diseases and cancers, as well have anti-aging effects. More recently stilbenoid compounds have shown promise in the treatment and prevention of neurodegenerative disorders, such as Huntington's, Parkinson's, and Alzheimer's diseases. This paper primarily focuses on the impact of stilbenoids in Alzheimer's disease and more specifically on the inhibition of beta-amyloid peptide aggregation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available